BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 9427577)

  • 1. Erythrocyte uroporphyrinogen decarboxylase activity: diagnostic value and relationship with clinical features in hereditary porphyria cutanea tarda.
    Camagna A; Del Duca P; Petrinelli P; Borelli LG; Ciancio L; Cipollone L; Misasi G; Manfredi MR; Dionisi S; de Martinis C
    Am J Med Sci; 1998 Jan; 315(1):59-62. PubMed ID: 9427577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Porphyria cutanea tarda and hepatoerythropoietic porphyria: Identification of 19 novel uroporphyrinogen III decarboxylase mutations.
    Weiss Y; Chen B; Yasuda M; Nazarenko I; Anderson KE; Desnick RJ
    Mol Genet Metab; 2019 Nov; 128(3):363-366. PubMed ID: 30514647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uroporphyrinogen decarboxylase: complete human gene sequence and molecular study of three families with hepatoerythropoietic porphyria.
    Moran-Jimenez MJ; Ged C; Romana M; Enriquez De Salamanca R; Taïeb A; Topi G; D'Alessandro L; de Verneuil H
    Am J Hum Genet; 1996 Apr; 58(4):712-21. PubMed ID: 8644733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of two types of porphyria cutanea tarda by measurement of erythrocyte uroporphyrinogen decarboxylase.
    Elder GH; Sheppard DM; De Salamanca RE; Olmos A
    Clin Sci (Lond); 1980 Jun; 58(6):477-84. PubMed ID: 7428280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Familial porphyria cutanea tarda in Spain: characterization of eight novel mutations in the UROD gene and haplotype analysis of the common p.G281E mutation.
    Gómez-Abecia S; Morán-Jiménez MJ; Ruiz-Casares E; Henriques-Gil N; García-Pastor I; Garrido-Astray MC; Enríquez de Salamanca R; Méndez M
    Gene; 2013 Jun; 522(1):89-95. PubMed ID: 23545314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A mutation (G281E) of the human uroporphyrinogen decarboxylase gene causes both hepatoerythropoietic porphyria and overt familial porphyria cutanea tarda: biochemical and genetic studies on Spanish patients.
    Roberts AG; Elder GH; De Salamanca RE; Herrero C; Lecha M; Mascaro JM
    J Invest Dermatol; 1995 Apr; 104(4):500-2. PubMed ID: 7706766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Porphyria cutanea tarda.
    Elder GH
    Semin Liver Dis; 1998; 18(1):67-75. PubMed ID: 9516680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Familial and sporadic porphyria cutanea tarda: clinical and biochemical features and risk factors in 152 patients.
    Muñoz-Santos C; Guilabert A; Moreno N; To-Figueras J; Badenas C; Darwich E; Herrero C
    Medicine (Baltimore); 2010 Mar; 89(2):69-74. PubMed ID: 20517178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatoerythropoietic porphyria and familial porphyria cutanea tarda in Spanish patients: G281E mutation in the uroporphyrinogen decarboxylase gene.
    Darwich E; To-Figueras J; Badenas C; Herrero C
    Arch Dermatol; 2010 Nov; 146(11):1313-4. PubMed ID: 21079081
    [No Abstract]   [Full Text] [Related]  

  • 10. Co-inheritance of mutations in the uroporphyrinogen decarboxylase and hemochromatosis genes accelerates the onset of porphyria cutanea tarda.
    Brady JJ; Jackson HA; Roberts AG; Morgan RR; Whatley SD; Rowlands GL; Darby C; Shudell E; Watson R; Paiker J; Worwood MW; Elder GH
    J Invest Dermatol; 2000 Nov; 115(5):868-74. PubMed ID: 11069625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Porphyria cutanea tarda, hepatitis C, uroporphyrinogen decarboxylase and mutations of HFE gene. A case-control study.
    Cribier B; Chiaverini C; Dali-Youcef N; Schmitt M; Grima M; Hirth C; Lacour JP; Chosidow O
    Dermatology; 2009; 218(1):15-21. PubMed ID: 19001803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complex pattern of alternative splicing in the normal uroporphyrinogen decarboxylase gene: implications for diagnosis of familial porphyria cutanea tarda.
    McManus JF; Begley CG; Ratnaike S
    Clin Chem; 1994 Oct; 40(10):1884-9. PubMed ID: 7923766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Red-cell uroporphyrinogen decarboxylase activity in porphyria cutanea tarda and in other forms of porphyria.
    Felsher BF; Norris ME; Shih JC
    N Engl J Med; 1978 Nov; 299(20):1095-8. PubMed ID: 703786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular heterogeneity of familial porphyria cutanea tarda in Spain: characterization of 10 novel mutations in the UROD gene.
    Méndez M; Poblete-Gutiérrez P; García-Bravo M; Wiederholt T; Morán-Jiménez MJ; Merk HF; Garrido-Astray MC; Frank J; Fontanellas A; Enríquez de Salamanca R
    Br J Dermatol; 2007 Sep; 157(3):501-7. PubMed ID: 17627795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Familial porphyria cutanea tarda: the pattern of porphyrins formed from porphobilinogen by hemolysates.
    Alleman MA; Wilson JH; van den Berg JW; Edixhoven-Bosdijk A; van Gastel-Quist LM
    Clin Chem; 1982 May; 28(5):1144-7. PubMed ID: 7074894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pathogenesis of porphyria cutanea tarda].
    Kószó F; Simon M
    Orv Hetil; 2000 Apr; 141(14):709-13. PubMed ID: 10803012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Familial and sporadic porphyria cutanea tarda: characterization and diagnostic strategies.
    Aarsand AK; Boman H; Sandberg S
    Clin Chem; 2009 Apr; 55(4):795-803. PubMed ID: 19233912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uroporphyrinogen decarboxylase gene mutations in Danish patients with porphyria cutanea tarda.
    Christiansen L; Bygum A; Jensen A; Brandrup F; Thomsen K; Horder M; Petersen NE
    Scand J Clin Lab Invest; 2000 Nov; 60(7):611-5. PubMed ID: 11202053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetics and pathogenesis of human uroporphyrinogen decarboxylase defects.
    Elder GH; Roberts AG; de Salamanca RE
    Clin Biochem; 1989 Jun; 22(3):163-8. PubMed ID: 2786774
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.